Evidence map›Paper›PMID 42625980›Full record

ArticleArchives of Razi Institute2025

Permethrin Resistancein Field Populations of

Valizadeh Abolfazl, Shirali Saloomeh, Solgi Rahmat, Khaksar Ehsan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Valizadeh AbolfazlDepartment of Pathobiology, SR.C., Islamic Azad University, Tehran, Iran.
Shirali SaloomehDepartment of Pathobiology, SR.C., Islamic Azad University, Tehran, Iran.
Solgi RahmatDepartment of Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Khaksar EhsanDepartment of Small Animal Internal Medicine, SR.C., Islamic Azad University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The high level of acaricide resistance in ticks has become a challenge for dog owners in Iran. Materials & Methods: This study was conducted in South Khorasan Province of Iran in 2024. In this study, the resistance status of Results: The LPT discriminating dose bioassays confirmed the pyrethroid resistance phenotype of the analyzed strains. The mortality rate at LC99 ranged between 38.1 and 49.1%. At the discriminating dose, survival rates ranged from 48.3% to 60.1%. Additionally, of the 40 ticks analyzed, mutations Conclusion: The presence of permethrin resistance in

Indexed as

AcaricidesDog DiseasesDrug ResistanceInsecticide ResistancePermethrinRhipicephalus sanguineusAnimalsDogsFemaleIranLarvaTick InfestationsAcaricidesPermethrinAcaricide resistanceDiagnostic concentrationPermethrinRhipicephalus sanguineus

Identifiers

PMID42625980
PMCPMC13490772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.